NYSEAMERICAN:INFU InfuSystem - INFU Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding InfuSystem Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $9.76 -0.01 (-0.10%) (As of 01/30/2023 12:00 AM ET) Add Compare Share Share Today's Range$9.67▼$9.9550-Day Range$7.56▼$10.0552-Week Range$6.10▼$15.49Volume16,168 shsAverage Volume48,646 shsMarket Capitalization$201.64 millionP/E Ratio976.98Dividend YieldN/APrice Target$22.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability InfuSystem MarketRank™ ForecastAnalyst RatingN/A0.00 Rating ScoreUpside/Downside125.4% Upside$22.00 Price TargetShort InterestHealthy0.53% of Float Sold ShortDividend StrengthN/ASustainability-1.20Upright™ Environmental ScoreNews SentimentN/AInsider TradingSelling Shares$1.05 M Sold Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.78 out of 5 stars 2.0 Analyst's Opinion Price Target Upside/DownsideAccording to analysts' consensus price target of $22.00, InfuSystem has a forecasted upside of 125.4% from its current price of $9.76.Amount of Analyst CoverageInfuSystem has received no research coverage in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted0.53% of the float of InfuSystem has been sold short.Short Interest Ratio / Days to CoverInfuSystem has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in InfuSystem has recently decreased by 3.91%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldInfuSystem does not currently pay a dividend.Dividend GrowthInfuSystem does not have a long track record of dividend growth. Previous Next 4.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreInfuSystem has received a 55.56% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Intravenous therapy equipment", "Medical dispensing pumps", and "Catheters" products. See details.Environmental SustainabilityThe Environmental Impact score for InfuSystem is -1.20. Previous Next 1.3 News and Social Media Coverage News SentimentInfuSystem has a news sentiment score of 0.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.72 average news sentiment score of Medical companies. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, InfuSystem insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,052,260.00 in company stock.Percentage Held by Insiders19.70% of the stock of InfuSystem is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions53.78% of the stock of InfuSystem is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of InfuSystem is 976.98, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 138.74.Price to Earnings Ratio vs. SectorThe P/E ratio of InfuSystem is 976.98, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 156.64.Price to Book Value per Share RatioInfuSystem has a P/B Ratio of 4.17. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About InfuSystem (NYSEAMERICAN:INFU) StockInfuSystem Holdings, Inc. engages in the provision of healthcare services. It operates through the Integrated Therapy Services and Durable Medical Equipment segments. The Integrated Therapy Services segment focuses on providing electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics, and hospital outpatient oncology clinics. The Durable Medical Equipment segment is involved in the rental, sale or leasing of pole-mounted and ambulatory infusion pumps to oncology practices, hospitals, and other clinical settings. The company was founded in August 2005 and headquartered in Rochester Hills, MI.Read More Receive INFU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter. Email Address INFU Stock News HeadlinesJanuary 23, 2023 | marketwatch.comInfusion Therapy Market 2023 : Trends, Industry Size, Share, Emerging Trends, Top Leading Players and Forecast 2028November 10, 2022 | finance.yahoo.comInfuSystem to Participate at 13th Annual Craig-Hallum Alpha Select Conference on November 17, 2022January 31, 2023 | Porter & Company (Ad)The Next Big Crisis Is HereYou just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.November 8, 2022 | finance.yahoo.comInfuSystem Reports Third Quarter 2022 Financial ResultsNovember 3, 2022 | finance.yahoo.comInfuSystem and Sanara MedTech Announce Wound Therapy PartnershipNovember 2, 2022 | finance.yahoo.comInfuSystem to Report Third Quarter 2022 Financial Results on November 8, 2022October 14, 2022 | finance.yahoo.comThe global home infusion therapy market is predicted to reach US$ 53.2 Billion by 2028 - Yahoo FinanceSeptember 23, 2022 | finance.yahoo.comInfuSystem Appoints R. Rimmy Malhotra to the Board of Directors - Yahoo FinanceJanuary 31, 2023 | Porter & Company (Ad)Is This The End of Capitalism?EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…September 23, 2022 | businesswire.comInfuSystem Appoints R. Rimmy Malhotra to the Board of Directors - Business WireSeptember 23, 2022 | finance.yahoo.comInfuSystem Appoints R. Rimmy Malhotra to the Board of DirectorsSeptember 16, 2022 | seekingalpha.comInfuSystem: Earnings Trends Justify Valuation Discount (NYSE:INFU) - Seeking AlphaSeptember 14, 2022 | seekingalpha.comINFU InfuSystem Holdings, Inc.September 7, 2022 | finance.yahoo.comInfuSystem to Participate in Lake Street’s 6th Annual Best Ideas Growth (BIG6) Conference September 14, 2022 - Yahoo FinanceSeptember 7, 2022 | businesswire.comInfuSystem to Participate in Lake Street's 6th Annual Best Ideas Growth (BIG6) Conference September 14, 2022 - Business WireAugust 31, 2022 | seekingalpha.comCove Street Capital 1H 2022 Letter To Shareholders - Seeking AlphaAugust 26, 2022 | stocknews.comALC: Is This Eye Care Stock a Buy as It Strikes $770M Buyout? - StockNews.comAugust 22, 2022 | benzinga.comLooking Into InfuSystems Holdings's Return On Capital Employed - BenzingaAugust 6, 2022 | uk.investing.comInfusystem Hldgs, Inc. Reports In-Line Q2 EPSAugust 6, 2022 | seekingalpha.comInfuSystem Holdings Inc. (INFU) CEO Rich DiIorio on Q2 2022 Results Earnings Call TranscriptAugust 6, 2022 | seekingalpha.comInfuSystem Holdings Inc. (INFU) CEO Rich DiIorio on Q2 2022 Results Earnings Call TranscriptAugust 5, 2022 | seekingalpha.comInfuSystem Q2 2022 Earnings PreviewAugust 5, 2022 | benzinga.comWhy NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday - BenzingaAugust 4, 2022 | investing.comInfusystem Hldgs, Inc. Reports In-Line Q2 EPS By Investing.com - Investing.comAugust 4, 2022 | ca.investing.comInfusystem Hldgs, Inc. Reports In-Line Q2 EPS By Investing.com - Investing.com CanadaAugust 4, 2022 | businesswire.comInfuSystem Reports Second Quarter 2022 Financial Results - Business WireAugust 4, 2022 | finance.yahoo.comInfuSystem Reports Second Quarter 2022 Financial ResultsSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive INFU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter. Email Address INFU Company Calendar Last Earnings11/08/2022Today1/30/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNYSEAMERICAN:INFU Previous SymbolNYSE:INFU CUSIPN/A CIK1337013 Webir.infusystem.com Phone(124) 291-1210Fax800-455-4338Employees394Year FoundedN/APrice Target and Rating Average Stock Price Forecast$22.00 High Stock Price Forecast$22.00 Low Stock Price Forecast$22.00 Forecasted Upside/Downside+125.4%Consensus RatingN/A Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)$0.01 Trailing P/E Ratio976.98 Forward P/E RatioN/A P/E GrowthN/ANet Income$1.42 million Net Margins0.28% Pretax Margin0.63% Return on Equity0.63% Return on Assets0.30% Debt Debt-to-Equity Ratio0.72 Current Ratio1.86 Quick Ratio1.48 Sales & Book Value Annual Sales$102.38 million Price / Sales1.97 Cash Flow$0.78 per share Price / Cash Flow12.46 Book Value$2.34 per share Price / Book4.17Miscellaneous Outstanding Shares20,660,000Free Float16,587,000Market Cap$201.64 million OptionableNot Optionable Beta1.15 Key ExecutivesRichard A. DilorioChief Executive Officer & DirectorCarrie A. LachancePresident, Chief Operating Officer & DirectorBarry G. SteeleChief Financial Officer & Executive Vice PresidentAddam ChupaChief Information Officer & Executive VPJeanie LatzSecretaryKey CompetitorsBeyond AirNASDAQ:XAIRQuipt Home MedicalNASDAQ:QIPTAVITA MedicalNASDAQ:RCELTELA BioNASDAQ:TELAAccurayNASDAQ:ARAYView All CompetitorsInsiders & InstitutionsGreenwood Capital Associates LLCBought 1,640 shares on 1/26/2023Ownership: 0.510%ARS Investment Partners LLCBought 3,644 shares on 1/25/2023Ownership: 0.193%Riverwater Partners LLCSold 15,976 shares on 1/12/2023Ownership: 0.246%Bank of New York Mellon CorpSold 5,339 shares on 12/8/2022Ownership: 0.212%Gregg Owen LehmanSold 25,000 sharesTotal: $218,500.00 ($8.74/share)View All Insider TransactionsView All Institutional Transactions INFU Stock - Frequently Asked Questions What is InfuSystem's stock price forecast for 2023? 0 Wall Street analysts have issued 12 month price targets for InfuSystem's shares. Their INFU share price forecasts range from $22.00 to $22.00. On average, they anticipate the company's stock price to reach $22.00 in the next twelve months. This suggests a possible upside of 125.4% from the stock's current price. View analysts price targets for INFU or view top-rated stocks among Wall Street analysts. How have INFU shares performed in 2023? InfuSystem's stock was trading at $9.30 on January 1st, 2023. Since then, INFU stock has increased by 4.9% and is now trading at $9.76. View the best growth stocks for 2023 here. Are investors shorting InfuSystem? InfuSystem saw a decrease in short interest during the month of December. As of December 30th, there was short interest totaling 99,700 shares, a decrease of 12.1% from the December 15th total of 113,400 shares. Based on an average trading volume of 37,100 shares, the short-interest ratio is currently 2.7 days. Currently, 0.6% of the shares of the company are sold short. View InfuSystem's Short Interest. How were InfuSystem's earnings last quarter? InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) released its quarterly earnings results on Tuesday, November, 8th. The medical instruments supplier reported $0.02 earnings per share (EPS) for the quarter. The medical instruments supplier had revenue of $27.28 million for the quarter. InfuSystem had a net margin of 0.28% and a trailing twelve-month return on equity of 0.63%. What guidance has InfuSystem issued on next quarter's earnings? InfuSystem issued an update on its FY 2022 earnings guidance on Thursday, December, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $112.00 million-$112.00 million, compared to the consensus revenue estimate of $112.67 million. What other stocks do shareholders of InfuSystem own? Based on aggregate information from My MarketBeat watchlists, some companies that other InfuSystem investors own include Macquarie Infrastructure (MIC), Ampio Pharmaceuticals (AMPE), Second Sight Medical Products (EYES), Navidea Biopharmaceuticals (NAVB), Otelco (OTEL), Pershing Gold (PGLC), Palatin Technologies (PTN), AgroFresh Solutions (AGFS), Advanced Micro Devices (AMD) and Digital Turbine (APPS). What is InfuSystem's stock symbol? InfuSystem trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU." Who are InfuSystem's major shareholders? InfuSystem's stock is owned by many different institutional and retail investors. Top institutional investors include Greenwood Capital Associates LLC (0.51%), Riverwater Partners LLC (0.25%), ARS Investment Partners LLC (0.19%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Barry G Steele, Blueline Capital Partners Ii,, Carrie Lachance, Christopher R Sansone, Gregg Owen Lehman, Jeannine Sheehan, Kevin Whitman, Meridian Ohc Partners, Lp, Paul Andrew Gendron, Richard Dilorio, Scott Shuda and Thomas Mark Ruiz. View institutional ownership trends. How do I buy shares of InfuSystem? Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is InfuSystem's stock price today? One share of INFU stock can currently be purchased for approximately $9.76. How much money does InfuSystem make? InfuSystem (NYSEAMERICAN:INFU) has a market capitalization of $201.64 million and generates $102.38 million in revenue each year. The medical instruments supplier earns $1.42 million in net income (profit) each year or $0.01 on an earnings per share basis. How many employees does InfuSystem have? The company employs 394 workers across the globe. How can I contact InfuSystem? InfuSystem's mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The official website for the company is ir.infusystem.com. The medical instruments supplier can be reached via phone at (124) 291-1210 or via fax at 800-455-4338. This page (NYSEAMERICAN:INFU) was last updated on 1/31/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.